Diagnosing and Managing Vulvar Dermatoses
Emily Murphy, MD, FAAD, is committed to improving care for vulvar dermatoses, which is why she founded the Vulvar Health Program at the George Washington University School of Medicine & Health Sciences. In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Dr. Murphy shares what her clinical experience has taught her about diagnosing and managing vulvar der …
Emily Murphy, MD, FAAD, is committed to improving care for vulvar dermatoses, which is why she founded the Vulvar Health Program at the George Washington University School of Medicine & Health Sciences. In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Dr. Murphy shares what her clinical experience has taught her about diagnosing and managing vulvar der … Continue reading "Diagnosing and Managing Vulvar Dermatoses"
Following up on insights shared at the ODAC Dermatology Conference, Dr. Neal Bhatia, MD, FAAD, Director of Clinical Dermatology at Therapeutics Clinical Research, offered a comprehensive overview of actinic keratosis (AK) management. Dr. Bhatia emphasized actionable approaches to balancing prescription topicals and procedural techniques in everyday practice.
The incidence for non-melanoma skin … 
ODAC Conference Co-Chair Susan Weinkle, MD, FAAD, is a scientist at heart, which means she’s frequently conducting aesthetic experiments on herself. In this Next Steps in Derm video interview, conducted in partnership with the ODAC Dermatology Conference, Dr. Weinkle shares some of the lessons she’s learned in 25 years of aesthetic self-treatment. For Dr. Weinkle, it’s meant admitting her se … 
Imaging is a mainstay of inpatient diagnostics. X-ray, MRI and CT scans are used to diagnose everything from broken bones to cancer. Yet these same imaging modalities are often ordered by hospitalists to diagnose dermatologic conditions even though the findings aren’t typically helpful in making an accurate diagnosis. These unnecessary tests are costly, delay an accurate diagnosis, and can add e … 
At the forefront of the evolving treatment landscape for cutaneous squamous cell carcinoma (cSCC), Dr. David M. Miller—a board-certified internist, dermatologist, and medical oncologist at Massachusetts General Hospital—delivered a highly informative lecture on the past, present, and future of immunotherapy for cSCC at ODAC 2025. With his unique expertise across three disciplines, Dr. Miller e …